Trademark: 90629077
Word
AMBIO
Status
Registered
Status Code
700
Status Date
Tuesday, October 18, 2022
Serial Number
90629077
Registration Number
6875075
Registration Date
Tuesday, October 18, 2022
Mark Type
4000
Filing Date
Wednesday, April 7, 2021
Published for Opposition
Tuesday, August 2, 2022

Trademark Owner History
Ambio Pharmaceuticals - Original Registrant

Classifications
42 Biochemical research and development; Pharmaceutical drug development services

Trademark Events
May 24, 2023
Assignment Of Ownership Not Updated Automatically
Oct 18, 2022
Notice Of Registration Confirmation Emailed
Oct 18, 2022
Registered-Principal Register
Aug 2, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2022
Published For Opposition
Jul 25, 2022
Teas Change Of Correspondence Received
Jul 25, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 25, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 13, 2022
Notification Of Notice Of Publication E-Mailed
Jun 29, 2022
Approved For Pub - Principal Register
Jun 27, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 30, 2021
Teas Change Of Correspondence Received
Nov 30, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 30, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 30, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 30, 2021
Examiner's Amendment Entered
Nov 30, 2021
Notification Of Examiners Amendment E-Mailed
Nov 30, 2021
Examiners Amendment E-Mailed
Nov 30, 2021
Examiners Amendment -Written
Nov 23, 2021
Assigned To Examiner
Jul 21, 2021
Preliminary/Voluntary Amendment - Entered
Jul 20, 2021
Assigned To Lie
Jun 29, 2021
Teas Voluntary Amendment Received
Jul 14, 2021
New Application Office Supplied Data Entered
Jun 28, 2021
Teas Change Of Correspondence Received
Jun 28, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Jun 28, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 28, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 10, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24